We are live on ! Find out more
FPC

Falcon Point Capital Portfolio holdings

AUM $11.9M
1-Year Est. Return 55.76%
This Fund
S&P 500
This Quarter Est. Return
-19.42%
1 Year Est. Return
+55.76%
3 Year Est. Return
+118.89%
5 Year Est. Return
+197.9%
10 Year Est. Return
AUM
$167M
AUM Growth
-$298M
Cap. Flow
-$222M
Cap. Flow %
-132.6%
Top 10 Hldgs %
29.81%
Holding
120
New
10
Increased
5
Reduced
70
Closed
18

Sector Composition

1 Industrials 20.48%
2 Healthcare 18.07%
3 Technology 17.67%
4 Consumer Discretionary 11.43%
5 Consumer Staples 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNDT
1
DELISTED
Mandiant, Inc. Common Stock
MNDT
$7.09M 4.24%
437,145
-587,577
-57% -$10.6M
JACK icon
2
Jack in the Box
JACK
$310M
$5.6M 3.35%
72,162
-94,310
-57% -$7.66M
FTAI icon
3
FTAI Aviation
FTAI
$20.9B
$5.12M 3.06%
417,798
-464,157
-53% -$6.47M
CZR icon
4
Caesars Entertainment
CZR
$6.09B
$5.09M 3.04%
140,644
-172,506
-55% -$6.85M
BEAT
5
DELISTED
BioTelemetry, Inc.
BEAT
$5M 2.99%
83,718
-113,167
-57% -$6.79M
OMCL icon
6
Omnicell
OMCL
$2.14B
$4.8M 2.87%
78,377
-105,322
-57% -$7.13M
PFPT
7
DELISTED
Proofpoint, Inc.
PFPT
$4.46M 2.67%
53,273
-69,720
-57% -$6.45M
STRA icon
8
Strategic Education
STRA
$1.76B
$4.35M 2.6%
38,338
-42,516
-53% -$5.42M
FIVN icon
9
FIVE9
FIVN
$1.93B
$4.27M 2.55%
97,572
-106,732
-52% -$4.29M
AGS
10
DELISTED
PlayAGS
AGS
$4.09M 2.44%
177,789
-208,265
-54% -$4.95M
MPT
11
Medical Properties Trust
MPT
$2.88B
$4.06M 2.42%
252,265
-315,254
-56% -$4.99M
SPNE
12
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$4.04M 2.42%
221,632
+150,312
+211% +$2.54M
NEO icon
13
NeoGenomics
NEO
$1.93B
$3.89M 2.32%
308,426
-358,547
-54% -$5.34M
CSOD
14
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$3.81M 2.28%
75,595
-99,441
-57% -$5.04M
IART icon
15
Integra LifeSciences
IART
$1.54B
$3.8M 2.27%
84,255
-116,720
-58% -$6.4M
CENTA icon
16
Central Garden & Pet Co Class A
CENTA
$2.44B
$3.68M 2.2%
147,273
-204,347
-58% -$4.89M
PRFT
17
DELISTED
Perficient Inc
PRFT
$3.4M 2.03%
152,878
-176,135
-54% -$4.32M
MTZ icon
18
MasTec
MTZ
$26.9B
$3.38M 2.02%
83,339
-115,549
-58% -$4.98M
LGND icon
19
Ligand Pharmaceuticals
LGND
$5.94B
$3.24M 1.94%
38,233
-32,192
-46% -$3.43M
BCO icon
20
Brink's
BCO
$4.85B
$3.22M 1.93%
49,866
-68,964
-58% -$4.55M
WIFI
21
DELISTED
Boingo Wireless, Inc.
WIFI
$3.16M 1.89%
153,674
-219,077
-59% -$5.83M
CONN
22
DELISTED
Conn's Inc.
CONN
$2.93M 1.75%
155,494
-197,377
-56% -$5.34M
CAMP
23
DELISTED
CalAmp Corp.
CAMP
$2.85M 1.7%
9,511
-8,360
-47% -$3.47M
WAGE
24
DELISTED
WageWorks, Inc.
WAGE
$2.72M 1.63%
100,173
-139,111
-58% -$5M
SUPN icon
25
Supernus Pharmaceuticals
SUPN
$2.8B
$2.7M 1.61%
81,223
-107,118
-57% -$4.61M

Similar funds

Falcon Point Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Falcon Point Capital held 120 positions worth $167M, down 64% from $466M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Falcon Point Capital withdrew a net $222M in Q4 2018, closing 18 positions and reducing 70 holdings. Its most notable exit was Deckers Outdoor, an estimated $7.11M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Falcon Point Capital opened a new position in Myriad Genetics worth $2.09M.

  • Falcon Point Capital's largest Q4 2018 buy was Myriad Genetics: 71,927 shares worth $2.09M.
  • Falcon Point Capital added most to SeaSpine Holdings Corporation Common Stock in Q4 2018, an estimated $2.54M increase.
  • Falcon Point Capital's biggest Q4 2018 reduction was Mandiant, Inc. Common Stock, cutting an estimated $10.6M.
  • Falcon Point Capital fully exited Deckers Outdoor in Q4 2018, selling an estimated $7.11M.
  • Falcon Point Capital's ten largest holdings make up 30% of its $167M portfolio in Q4 2018.
  • Falcon Point Capital opened 10 new positions and closed 18 in Q4 2018.
  • Falcon Point Capital's portfolio value fell 64% quarter-over-quarter to $167M.

Based on Falcon Point Capital's 13F filing for Q4 2018, filed 31 Jan 2019.